Matthew Perry
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
-
- Breast Cancer Treatment Studies
Papers in
- Co-authors
- James E. Herndon (2 shared papers)Thomas E. Novotny (1 shared paper)Ross C. Brownson (1 shared paper)Walter L. Eaton (1 shared paper)James E. Wooldridge (1 shared paper)Joseph Aisner (2 shared papers)Sandra J. Ginsberg (1 shared paper)J F Holland (1 shared paper)
- Journals
- CA A Cancer Journal for Clinicians (2 papers)Journal of Clinical Oncology (2 papers)The Journal of Urology (2 papers)JNCI Journal of the National Cancer Institute (2 papers)PubMed (3 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Matthew Perry
10 papers receiving 461 citations
Peers
Comparison fields: 5 of 72
- Oncology 253
- Cancer Research 67
- Hematology 42
- Pulmonary and Respiratory Medicine 110
- Genetics 24
Countries citing papers authored by Matthew Perry
This map shows the geographic impact of Matthew Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Perry more than expected).
Fields of papers citing papers by Matthew Perry
This network shows the impact of papers produced by Matthew Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Perry. The network helps show where Matthew Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 101 | |
| 2 | 2002 | 95 | |
| 3 | 1998 | 94 | |
| 4 | Cigarette smoking and adult leukemia. A meta-analysis. | 1993 | 88 |
| 5 | Corticosteroids in advanced cancer. | 2001 | 52 |
| 6 | 1993 | 32 | |
| 7 | 1981 | 17 | |
| 8 | 1993 | 17 | |
| 9 | 2012 | 6 | |
| 10 | Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial. | 1982 | 4 |
| 11 | 2010 | 0 |
About Matthew Perry
Matthew Perry is a scholar working on Oncology, Urology, Surgery, Biotechnology and Genetics, having authored 11 papers that have together received 506 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (3 papers), Genital Health and Disease (2 papers), Acute Myeloid Leukemia Research (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Cancer Research and Treatments (1 paper), Management of metastatic bone disease (1 paper), Immunotherapy and Immune Responses (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Oncology (253 citations), Cancer Research (67 citations), Hematology (42 citations), Pulmonary and Respiratory Medicine (110 citations) and Genetics (24 citations). Matthew Perry has collaborated with scholars based in United States and Canada. Frequent co-authors include James E. Herndon, Thomas E. Novotny, Ross C. Brownson, Walter L. Eaton, James E. Wooldridge, Joseph Aisner, Sandra J. Ginsberg, J F Holland, VIVIAN K. WEINBERG and Michael D. Perloff. Their work appears in journals such as CA A Cancer Journal for Clinicians, Journal of Clinical Oncology, The Journal of Urology, JNCI Journal of the National Cancer Institute and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.